Article Details
Retrieved on: 2022-12-06 17:05:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Only 22% of all Alzheimer's therapy approvals have been for biologics, with monoclonal antibodies accounting for 11% of these.
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here